Suman Dash

3PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 31, 2024
Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.

Suman Dash, Takeshi Ueda, Akiyoshi Komuro

|Feb 12, 2024
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.

Suman Dash, Takeshi Ueda, Akiyoshi Komuro

|Feb 09, 2023
MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance.

Suman Dash, Takeshi Ueda, Akiyoshi Komuro

Pageof 1

Frequent Collaborators

3 joint publications

Takeshi Ueda

3 joint publications

Hitoshi Okada

2 joint publications

Ryoichi Sugisawa

1 joint publications

Akiyoshi Komuro